IT1303684B1 - Formulazioni di apomorfina in soluzione stabili nel tempo. - Google Patents

Formulazioni di apomorfina in soluzione stabili nel tempo.

Info

Publication number
IT1303684B1
IT1303684B1 IT1998MI002331A ITMI982331A IT1303684B1 IT 1303684 B1 IT1303684 B1 IT 1303684B1 IT 1998MI002331 A IT1998MI002331 A IT 1998MI002331A IT MI982331 A ITMI982331 A IT MI982331A IT 1303684 B1 IT1303684 B1 IT 1303684B1
Authority
IT
Italy
Prior art keywords
apomorphine
formulations
over time
stable over
solution stable
Prior art date
Application number
IT1998MI002331A
Other languages
English (en)
Italian (it)
Inventor
Eva Bernini
Gaetano Brambilla
Paolo Chiesi
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Priority to IT1998MI002331A priority Critical patent/IT1303684B1/it
Priority to GR990100373A priority patent/GR990100373A/el
Priority to GB9925602A priority patent/GB2343376B/en
Priority to ES009902380A priority patent/ES2156763B1/es
Priority to FR9913521A priority patent/FR2785188B1/fr
Priority to BR9905305-5A priority patent/BR9905305A/pt
Publication of ITMI982331A1 publication Critical patent/ITMI982331A1/it
Application granted granted Critical
Publication of IT1303684B1 publication Critical patent/IT1303684B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT1998MI002331A 1998-10-30 1998-10-30 Formulazioni di apomorfina in soluzione stabili nel tempo. IT1303684B1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT1998MI002331A IT1303684B1 (it) 1998-10-30 1998-10-30 Formulazioni di apomorfina in soluzione stabili nel tempo.
GR990100373A GR990100373A (el) 1998-10-30 1999-10-27 Σταθερες συνθεσεις διαλυματων απομορφινης
GB9925602A GB2343376B (en) 1998-10-30 1999-10-28 Stable apomorphine solution formulations
ES009902380A ES2156763B1 (es) 1998-10-30 1999-10-28 Formulaciones estables de solucion de apomorfina.
FR9913521A FR2785188B1 (fr) 1998-10-30 1999-10-28 Formulations stables d'apomorphine en solution
BR9905305-5A BR9905305A (pt) 1998-10-30 1999-10-29 Formulações estáveis em solução de apomorfina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002331A IT1303684B1 (it) 1998-10-30 1998-10-30 Formulazioni di apomorfina in soluzione stabili nel tempo.

Publications (2)

Publication Number Publication Date
ITMI982331A1 ITMI982331A1 (it) 2000-04-30
IT1303684B1 true IT1303684B1 (it) 2001-02-23

Family

ID=11380970

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1998MI002331A IT1303684B1 (it) 1998-10-30 1998-10-30 Formulazioni di apomorfina in soluzione stabili nel tempo.

Country Status (6)

Country Link
BR (1) BR9905305A (fr)
ES (1) ES2156763B1 (fr)
FR (1) FR2785188B1 (fr)
GB (1) GB2343376B (fr)
GR (1) GR990100373A (fr)
IT (1) IT1303684B1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0202797A3 (en) * 1999-09-29 2004-05-28 Procter & Gamble Compositions having improved stability
TW200526268A (en) * 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition
TW201035054A (en) * 2009-02-27 2010-10-01 Lundbeck & Co As H Methods of administering (4aR, 10aR)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diol and pharmaceutical compositions thereof
HUE042425T2 (hu) 2012-06-05 2019-06-28 Neuroderm Ltd Apomorfint és szerves savakat tartalmazó készítmények és alkalmazásaik
WO2015157212A1 (fr) * 2014-04-10 2015-10-15 Us Worldmeds, Llc Composition stable d'apomorphine et ses utilisations

Also Published As

Publication number Publication date
GB2343376A (en) 2000-05-10
BR9905305A (pt) 2001-03-20
ITMI982331A1 (it) 2000-04-30
GB9925602D0 (en) 1999-12-29
FR2785188B1 (fr) 2004-10-29
GR990100373A (el) 2000-06-30
FR2785188A1 (fr) 2000-05-05
ES2156763B1 (es) 2002-03-01
GB2343376B (en) 2003-12-31
ES2156763A1 (es) 2001-07-01

Similar Documents

Publication Publication Date Title
DE69838130D1 (de) Riechstoffzusammensetzungen
ID27415A (id) Komposisi farmaseutik
NO20010046D0 (no) Dolastatin-15-derivater
ID28833A (id) Turunan asam 3-aril-2-hidroksipropionat
DK1156806T3 (da) Farmaceutisk sammensætning indeholdende protonpumpeinhibitor
ATE293970T1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
IS5555A (is) Selekoxib lyfjablöndur
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
DE60134423D1 (de) Flammhemmende polycarbonat-polyester zusammensetzung
NO20004240L (no) Formuleringer
PT1001813E (pt) Formulacoes farmaceuticas contendo voriconazole
ATE224703T1 (de) Brauseformulierungen
PT1130966E (pt) Formulacoes antiparasitarias
ID29262A (id) Komposisi farmasi
NO20012265D0 (no) Dispergerbare blandinger inneholdende L-DOPA-etylester
RS50071B (sr) Novi oblik soli pantoprazola
DK0968719T3 (da) Enzymsammensætning, der er i stand til at danne et oligosaccharid in vivo
ATE279114T1 (de) Dermal applizierbare wasserhaltige formulierungen von parasitiziden
PT869121E (pt) Derivados de propanolamina hipolipidemicos
DE69935609D1 (de) Formulierungen enthaltend cefuroxim-axetil
DE69926907T2 (de) Bleichungzusammensetzungen
FR2737115B1 (fr) Composition stable contenant une enzyme
DE59904464D1 (de) Doppelpumpen-aggregat
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.